- Joined
- Aug 14, 2012
- Messages
- 982
- Reaction score
- 9
- Points
- 4,551
Specifically related to 5-HT, I've read conflicting things and was hoping one of you could provide a bit of clarity:
One side - General 5-HT receptor antagonist, except for partial agonism at 5-HT1A
The other - 5-HT reuptake inhibition
TYIA for any help!
Well, I don't particularly like North Carolina, but I detest Duke. Not all antagonism is the same.
It's best to think of trazodone as a 2A antagonist and 1A partial agonist (like buspirone), as well as an H1/M1 blocker, and consider the other bindings weak enough to be apparently not significant at the doses used. For example, though a 2C blocker, trazodone is not usually associated with metabolic syndrome.
Even better than Ibid's encouragement of doublethink, I would leave you considering a fratboy at a wet t-shirt contest. He throws a bucket of water on the girls, and suddenly the girls are cooled down, but the fratboys find them much hotter. There is some profundity regarding psychopharmacology buried in this, though it may require some sandblasting to uncover.

In the psychiatric assessment, humour is a pathology. If you joke in front of a psychiatrist, the response can be quite brutal. This is because the psychiatrist is at the zenith of power, where they don't so much lack humour, so much as embody it. Laughter is therefore forbidden. It is a sign of illness. A heckling of the comedian. The breaking of the fourth wall. They can laugh at you, and you can laugh at them, but it must be done in separate rooms. Else, they'd be "unprofessional" and you'd be "inappropriate".
Stahl published a worthwhile review article on trazodone. I don't have the paper in front of me at the moment, but it should be easily found if you have institution/hospital access to the typical online databases.
*edit*
Stahl SM. Mechanism of action of trazodone: a multifunctional drug. CNS Spectr. 2009 Oct;14(10):536-46.
http://www.cnsspectrums.com/UserDocs/ArticleImages/176/1009CNS_Stahl.pdf
Stahl published a worthwhile review article on trazodone. I don't have the paper in front of me at the moment, but it should be easily found if you have institution/hospital access to the typical online databases.
*edit*
Stahl SM. Mechanism of action of trazodone: a multifunctional drug. CNS Spectr. 2009 Oct;14(10):536-46.
http://www.cnsspectrums.com/UserDocs/ArticleImages/176/1009CNS_Stahl.pdf
Stahl said:Furthermore, the sustained blood levels generated by trazadone XR are theoretically ideal for causing tolerance to the side effect of sedation
Seems like the kind of statement that shouldn't be without some kind of citation.
Stahl definitely isn't perfect, though I think he does a better job than most when it comes to backing up his statements with research. With that being said, if it was indeed pharma funding (I didn't recall that being the case), then YMMV.
Hope I didn't come across as critical of your sharing it